Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2014, 15(4), 5852-5873; doi:10.3390/ijms15045852
Review

Nanoparticle-Mediated Pulmonary Drug Delivery: A Review

 and *
Received: 22 January 2014; in revised form: 28 March 2014 / Accepted: 28 March 2014 / Published: 8 April 2014
(This article belongs to the Special Issue Nanotoxicology and Lung Diseases)
View Full-Text   |   Download PDF [377 KB, uploaded 19 June 2014]
Abstract: Colloidal drug delivery systems have been extensively investigated as drug carriers for the application of different drugs via different routes of administration. Systems, such as solid lipid nanoparticles, polymeric nanoparticles and liposomes, have been investigated for a long time for the treatment of various lung diseases. The pulmonary route, owing to a noninvasive method of drug administration, for both local and systemic delivery of an active pharmaceutical ingredient (API) forms an ideal environment for APIs acting on pulmonary diseases and disorders. Additionally, this route offers many advantages, such as a high surface area with rapid absorption due to high vascularization and circumvention of the first pass effect. Aerosolization or inhalation of colloidal systems is currently being extensively studied and has huge potential for targeted drug delivery in the treatment of various diseases. Furthermore, the surfactant-associated proteins present at the interface enhance the effect of these formulations by decreasing the surface tension and allowing the maximum effect. The most challenging part of developing a colloidal system for nebulization is to maintain the critical physicochemical parameters for successful inhalation. The following review focuses on the current status of different colloidal systems available for the treatment of various lung disorders along with their characterization. Additionally, different in vitro, ex vivo and in vivo cell models developed for the testing of these systems with studies involving cell culture analysis are also discussed.
Keywords: nanoparticles; SLN; toxicity; lung cell models; aerosol; nebulization; lung disease nanoparticles; SLN; toxicity; lung cell models; aerosol; nebulization; lung disease
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Paranjpe, M.; Müller-Goymann, C.C. Nanoparticle-Mediated Pulmonary Drug Delivery: A Review. Int. J. Mol. Sci. 2014, 15, 5852-5873.

AMA Style

Paranjpe M, Müller-Goymann CC. Nanoparticle-Mediated Pulmonary Drug Delivery: A Review. International Journal of Molecular Sciences. 2014; 15(4):5852-5873.

Chicago/Turabian Style

Paranjpe, Mukta; Müller-Goymann, Christel C. 2014. "Nanoparticle-Mediated Pulmonary Drug Delivery: A Review." Int. J. Mol. Sci. 15, no. 4: 5852-5873.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert